Research uncovers a potential role of two proteins in diabetes

May 20, 2013
Research uncovers a potential role of two proteins in diabetes
Credit: Associate Professor Catherine Abbott (left) and Dr Claire Wilson

(Medical Xpress)—Flinders University researchers are breaking new ground in a decade-long journey to pinpoint the function of two closely related proteins.

They now have data that reveals a role for these proteins in regulating . Disturbances in metabolism underlie a number of human diseases including type 2 diabetes, obesity and cancer.

The team, led by Associate Professor Catherine Abbott from the School of , has discovered that two proteins called dipeptidyl peptidases (DP) 8 and 9 play a role in regulating at least 29 other proteins, many of which play important roles in metabolism and .

As a way to control , people with that do not respond to the drug are given januvia or sitagliptin, a drug to supress dipeptidyl peptidase-4 (DP4), which belongs to the same family of proteins as DP 8 and 9.

However, Associate Professor Abbott said that when tested at high doses these drugs also inhibited DP 8 and 9.

She said more research was now needed to determine the exact role of DP 8 and 9 because "we don't know whether they have a positive effect on metabolism and energy and managing glucose levels or a negative effect".

"Pharmaceutical companies claim their drugs are selective and don't bind to other proteins but in high doses there's a possibility they could," said Associate Professor Abbott.

"What we need to find out, and what this study suggests, is that if these drugs do block DP 8 and 9 it might not necessarily be a bad thing because DP 8 and 9 could also be targets in the treatment of diabetes," she said.

"On the other hand, blocking them might affect metabolism and energy in an adverse way, which could make the DP4 inhibitors unsafe."

The research has just been published in the international Journal of Biological Chemistry as "Paper of the Week".

Only 50 to 100 papers are chosen as Paper of the Week from more than 6000 manuscripts published in the journal each year, based on their significance and overall importance to the understanding of biological processes at a molecular and cellular level.

Associate Professor Abbott, who discovered DP 8 and 9 more than 10 years ago, said the proteins and DP4 may also play a role in tumour growth, therefore a better understanding of their function could also led to increased confidence in the safety of DP4 inhibitors or in a new use for inhibitors as a cancer therapy.

Explore further: Mapping of cancer cell fuel pumps paves the way for new drugs

More information: www.jbc.org/cgi/doi/10.1074/jbc.M112.445841

Related Stories

Mapping of cancer cell fuel pumps paves the way for new drugs

April 28, 2013
For the first time, researchers at Karolinska Institutet in Sweden have managed to obtain detailed images of the way in which the transport protein GLUT transports sugars into cells. Since tumours are highly dependent on ...

Research to end asbestos-related cancer

May 16, 2013
Scientists from Flinders University are trying to develop a new treatment for a highly aggressive, asbestos-related lung cancer that is set to become more prevalent in the future.

Abbott Laboratories recalls blood glucose meters

April 15, 2013
Abbott Laboratories is recalling its FreeStyle InsuLinx Blood Glucose Meters after finding that they display and store incorrect test results for dangerously high blood sugar levels.

Bevacizumab doesn't up overall survival in prostate cancer

March 27, 2012
(HealthDay) -- For men with metastatic castration-resistant prostate cancer (mCRPC), the addition of bevacizumab (B) to docetaxel plus prednisone (DP) is not associated with improved overall survival (OS), but does improve ...

Study reveals how diabetes drug delays ageing in worms

March 28, 2013
A widely prescribed type 2 diabetes drug slows down the ageing process by mimicking the effects of dieting, according to a study published today using worms to investigate how the drug works.

Recommended for you

Screen time linked to diabetes

July 28, 2017
Daily screen time of three or more hours is linked to several risk factors associated with the development of diabetes in children, according to a study by St George's, University of London.

People who drink 3 to 4 times per week less likely to develop diabetes than those who never drink: study

July 27, 2017
Frequent alcohol consumption is associated with a reduced risk of diabetes in both men and women, according to a new study published in Diabetologia (the journal of the European Association for the Study of Diabetes), with ...

Diabetes can be tracked with our Google searches

July 26, 2017
The emergence of Type 2 Diabetes could be more effectively monitored using our Google searches—helping public health officials keep track of the disease and halt its spread—according to research by the University of Warwick.

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.